Replimune Group, Inc. (REPL) vs Y-mAbs Therapeutics, Inc. (YMAB)
Detailed comparison between Replimune Group, Inc., Y-mAbs Therapeutics, Inc..Total Return (%)
Replimune Group, Inc. (REPL)Y-mAbs Therapeutics, Inc. (YMAB)
Which stock do you think will perform better?
Replimune Group, Inc.
REPL
Y-mAbs Therapeutics, Inc.
YMAB
| Metric | Replimune Group, Inc. (REPL) | Y-mAbs Therapeutics, Inc. (YMAB) |
|---|---|---|
| Current Price | $8.98 | $4.60 |
| Change | -0.39 (-4.16%) | -0.15 (-3.16%) |
| Market Cap | $0.69B | $0.21B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -3.34 | -7.93 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $17.00 | $16.11 |
| 52-Week Low | $4.93 | $3.55 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-3.07 | $-0.64 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| REPL | -10.29% | -34.50% | 65.07% | -54.55% | -40.77% | -40.77% |
| YMAB | 4.31% | -20.69% | -61.89% | -89.29% | -80.83% | -80.83% |